Author

Hong-Yu Liu

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Greater survival benefits in small cell lung cancer patients: a real-world study with immune checkpoint inhibitors therapy

Background Small-cell lung cancer (SCLC) is a highly aggressive neuroendocrine malignancy. Immune checkpoint inhibitors (ICIs) combined with chemotherapy have become a standard first-line treatment for extensive-stage SCLC; however, their effectiveness across different clinical settings in real-world practice remains i...

Peng-Hu Gao, Hong-Bing Zhang, Ming-Hui Liu et al. · Frontiers in Oncology · 0 citations

Open access Aug 2026

Ascomycin enhances the antitumor activity of osimertinib in EGFR-TKI-resistant non-small cell lung cancer

Background Resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) remains a major challenge in non-small cell lung cancer (NSCLC) treatment. Although ascomycin (FK520) has demonstrated some antitumor activity, its potential in overcoming osimertinib resistance has not been fully character...

Hong-Bing Zhang, Chen Chen, Di Wu et al. · Frontiers in Oncology · 0 citations